Ishares Trust U.S. Pharmaceuticals Etf Newsroom

Cantor Fitzgerald Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $885

Moomoo NewsJul 25 08:31 ET

Zoetis Price Target Announced at $220.00/Share by BTIG

Dow JonesJul 25 08:30 ET

Zoetis Analyst Ratings

BenzingaJul 25 08:16 ET

BTIG Initiates Zoetis(ZTS.US) With Buy Rating, Announces Target Price $220

Moomoo NewsJul 25 07:57 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 24 15:47 ET

Wolfe Research Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,117

Moomoo NewsJul 24 15:31 ET

Wolfe Research Adjusts Eli Lilly's Price Target to $1,117 From $909

MT NewswiresJul 24 12:23 ET

Buy Rating Affirmed: Sangamo's Hemophilia A Gene Therapy Poised for Success With Pfizer Partnership

TipRanksJul 24 10:27 ET

Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Maintains Target Price $13

Moomoo NewsJul 24 07:31 ET

Jefferies Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $200

Moomoo NewsJul 23 11:32 ET

Buy Rating Affirmed for Zoetis Amidst Favorable Market Dynamics and Strong Growth Potential

TipRanksJul 23 11:19 ET

Hold Rating on Bristol-Myers Squibb Amid Mixed Performance and Evolving Pipeline

TipRanksJul 23 07:34 ET

Deutsche Numis Initiates Bristol-Myers Squibb(BMY.US) With Hold Rating, Announces Target Price $45

Moomoo NewsJul 23 07:31 ET

Johnson & Johnson Analyst Ratings

BenzingaJul 23 05:36 ET

Daiwa Downgrades Johnson & Johnson to Neutral From Outperform, Adjusts Price Target to $150 From $160

MT NewswiresJul 23 05:25 ET

Bristol-Myers Squibb Analyst Ratings

BenzingaJul 22 11:24 ET

Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com

Barron'sJul 22 08:58 ET

Guggenheim Adjusts Johnson & Johnson's Price Target to $156 From $160, Maintains Neutral Rating

MT NewswiresJul 22 07:55 ET

Intra-Cellular Therapies Analyst Ratings

BenzingaJul 22 05:31 ET

Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $100

BenzingaJul 22 05:31 ET